Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105529997 | 10552999 | 7 | F | 201307 | 20160712 | 20141029 | 20160722 | EXP | BR-ABBVIE-14K-020-1279296-00 | ABBVIE | 37.25 | YR | F | Y | 111.00000 | KG | 20160722 | CN | COUNTRY NOT SPECIFIED | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 105529997 | 10552999 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | 59126XH02 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||
| 105529997 | 10552999 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | 59126XH02 | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | ||||||
| 105529997 | 10552999 | 3 | C | SERTRALINE HYDROCHLORIDE. | SERTRALINE HYDROCHLORIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 105529997 | 10552999 | 4 | C | SERTRALINE HYDROCHLORIDE. | SERTRALINE HYDROCHLORIDE | 1 | Oral | 0 | TABLET | ||||||||||
| 105529997 | 10552999 | 5 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | 112 | UG | TABLET | QD | |||||||
| 105529997 | 10552999 | 6 | C | PURAN | LEVOTHYROXINE SODIUM | 1 | Oral | 0 | TABLET | ||||||||||
| 105529997 | 10552999 | 7 | C | PREDNISONE. | PREDNISONE | 1 | Oral | 0 | TABLET | ||||||||||
| 105529997 | 10552999 | 8 | C | PREDNISONE. | PREDNISONE | 1 | Topical | 0 | OINTMENT | ||||||||||
| 105529997 | 10552999 | 9 | C | TRAMAL | TRAMADOL | 1 | Other | 0 | INJECTION | ||||||||||
| 105529997 | 10552999 | 10 | C | MAREVAN | WARFARIN SODIUM | 1 | Oral | 0 | 5 | MG | TABLET | QD | |||||||
| 105529997 | 10552999 | 11 | C | MAREVAN | WARFARIN SODIUM | 1 | 0 | ||||||||||||
| 105529997 | 10552999 | 12 | C | TEGRETARD | CARBAMAZEPINE | 1 | Oral | 0 | TABLET | ||||||||||
| 105529997 | 10552999 | 13 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Oral | 0 | 80 | MG | TABLET | BID | |||||||
| 105529997 | 10552999 | 14 | C | WARFARIN SODIUM. | WARFARIN SODIUM | 1 | Oral | 0 | 5 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 105529997 | 10552999 | 1 | Rheumatoid arthritis |
| 105529997 | 10552999 | 3 | Anxiety |
| 105529997 | 10552999 | 5 | Hypothyroidism |
| 105529997 | 10552999 | 7 | Arthritis |
| 105529997 | 10552999 | 8 | Nodule |
| 105529997 | 10552999 | 9 | Pain |
| 105529997 | 10552999 | 10 | Anticoagulant therapy |
| 105529997 | 10552999 | 11 | Pulmonary embolism |
| 105529997 | 10552999 | 12 | Anxiety |
| 105529997 | 10552999 | 13 | Gastric disorder |
| 105529997 | 10552999 | 14 | Anticoagulant therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 105529997 | 10552999 | HO |
| 105529997 | 10552999 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 105529997 | 10552999 | Benign fallopian tube neoplasm | |
| 105529997 | 10552999 | Benign ovarian tumour | |
| 105529997 | 10552999 | Benign uterine neoplasm | |
| 105529997 | 10552999 | Blood test abnormal | |
| 105529997 | 10552999 | Cholelithiasis | |
| 105529997 | 10552999 | Crohn's disease | |
| 105529997 | 10552999 | Diarrhoea | |
| 105529997 | 10552999 | Dysmenorrhoea | |
| 105529997 | 10552999 | Gastrointestinal injury | |
| 105529997 | 10552999 | Menstruation irregular | |
| 105529997 | 10552999 | Musculoskeletal pain | |
| 105529997 | 10552999 | Musculoskeletal stiffness | |
| 105529997 | 10552999 | Nephrolithiasis | |
| 105529997 | 10552999 | Nodule | |
| 105529997 | 10552999 | Ovarian enlargement | |
| 105529997 | 10552999 | Pain | |
| 105529997 | 10552999 | Polycystic ovaries | |
| 105529997 | 10552999 | Pulmonary embolism | |
| 105529997 | 10552999 | Rheumatoid arthritis | |
| 105529997 | 10552999 | Scar | |
| 105529997 | 10552999 | Skin mass | |
| 105529997 | 10552999 | Uterine enlargement | |
| 105529997 | 10552999 | Uterine leiomyoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 105529997 | 10552999 | 1 | 20130611 | 20140815 | 0 | |
| 105529997 | 10552999 | 2 | 2014 | 20160131 | 0 | |
| 105529997 | 10552999 | 3 | 201309 | 0 | ||
| 105529997 | 10552999 | 4 | 2014 | 0 | ||
| 105529997 | 10552999 | 5 | 2008 | 0 | ||
| 105529997 | 10552999 | 6 | 2010 | 0 | ||
| 105529997 | 10552999 | 7 | 2010 | 0 | ||
| 105529997 | 10552999 | 8 | 201411 | 0 | ||
| 105529997 | 10552999 | 10 | 201307 | 0 | ||
| 105529997 | 10552999 | 12 | 201601 | 0 | ||
| 105529997 | 10552999 | 13 | 201503 | 0 | ||
| 105529997 | 10552999 | 14 | 201307 | 0 |